Study of REGN475 in Patients With Pain Due to Osteoarthritis of the Knee or Hip

Completed · Phase 2/Phase 3 · Has a placebo group

Conditions studied: Osteoarthritis, Knee, Osteoarthritis, Hip

In brief

The primary objective of this study is to evaluate the effectiveness of REGN475 compared to placebo in participants with pain due to osteoarthritis (OA) of the knee or hip and a history of inadequate joint pain relief or intolerance to current analgesic therapy.

Key facts

Study ID
NCT02447276
Run by
Regeneron Pharmaceuticals
People needed
421
Starts
2015-05-01
Expected to finish
2016-11-01
Last updated by the study team
2017-03-27

Who can join

Age: 40 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.